B+
Bull case
25%
Probability
Target price
$68.00
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
ACU
Acme UnitedCNYSE American / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$57.00
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$45.00
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-07-28
Recent news sentiment (30D)
+0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+56.1
Score
AI commentary
Tone improved materially after Q2: the company reported record revenue and operating income, and secondary coverage described a strong initial market reaction. However, the six-month earnings decline, persistent tariff exposure, limited analyst revisions, absent social context, and loose peer set support a monitoring view rather than a high-conviction bullish thesis.
RankAlpha Sentiment Codex - 2026-07-28
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-07-23eventQ2 2026 earnings beat and positive initial reactionHigh impact
The SEC-filed earnings release reported Q2 sales of $62.7 million, up 16%, EPS of $1.22, up 5%, comparable sales growth of 8% excluding MyMedic, and gross margin expansion to 42.6% [#SEC-8K-2026-07-23]. Secondary coverage reported EPS above the $0.81 consensus estimate and an initial premarket gain of approximately 12%.
2026-09-30catalystGradual tariff-related margin normalizationMedium impact
Management said elevated-tariff inventory continued to pressure U.S. margins but that the impact was lower than in Q1 and should decrease in coming quarters [#SEC-8K-2026-07-23].
2026-12-31catalystMyMedic integration and Q4 seasonal profitabilityHigh impact
MyMedic contributed sales but had minimal Q2 earnings impact because profitability is historically concentrated in Q4. Management is pursuing retail expansion, sourcing savings, and overhead reduction [#SEC-8K-2026-07-23].
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-28 • Updated nightlySource: Internal modelMethodology